(Q44126707)

30 November 2017

Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice (English)

1 reference

30 November 2017

Mohammad-Reza Zarrindast

series ordinal

1

object named as

Mohammad-Reza Zarrindast

1 reference

30 November 2017

Taraneh Bahreini

2

1 reference

PubMed ID

12213541

30 November 2017

Mohammad Adl

series ordinal

3

1 reference

PubMed ID

12213541

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Pharmacology, Biochemistry and Behavior

30 November 2017

1 reference

30 November 2017

73

1 reference

30 November 2017

941-949

1 reference

30 November 2017

4

1 reference

Clonidine produces a conditioned place preference in rats.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Antidepressants and opiates interactions: pharmacological and biochemical evidences.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Differences in drug-induced place conditioning between BALB/c and C57Bl/6 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Conditioned place preference: an evaluation of morphine's positive reinforcing properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Clonidine-induced place preference is mediated by alpha 2-adrenoceptors outside the locus coeruleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Aversive and appetitive properties of anxiogenic and anxiolytic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Differential mechanisms in the acquisition and expression of heroin-induced place preference.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

The use of place conditioning in studying the neuropharmacology of drug reinforcement.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Drugs of abuse: anatomy, pharmacology and function of reward pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Effect of chronic administration of antidepressants on alpha 2-adrenoceptors in the locus coeruleus and its projection fields in rat brain determined by quantitative autoradiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Imipramine Treatment of Painful Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Differential effects of antidepressant treatment on brain monoaminergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Place preference conditioning with methylphenidate and nomifensine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Measuring morphine's capacity to establish a place preference.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

The dopamine hypothesis of reward: past and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Effect of yohimbine hydrochloride on erectile impotence: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Blockade of morphine-induced place preference by diazepam in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Implication of endogenous opioid system in the learned helplessness model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Tricyclic Antidepressants: Therapeutic Properties and Affinity for α-Noradrenergic Receptor Binding Sites in the Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

In search of the mode of action of antidepressants 5-HTP/tyrosine mixtures in depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Adenosine receptor agents and conditioned place preference.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

Clonidine antagonizes the aversive effects of opiate withdrawal and the rewarding effects of morphine only in opiate withdrawn rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2802%2900951-6

7 January 2021

10.1016/S0091-3057(02)00951-6

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12213541